LPTX
Price
$0.39
Change
-$0.01 (-2.50%)
Updated
Jun 6 closing price
Capitalization
16.38M
SLS
Price
$1.61
Change
-$0.02 (-1.23%)
Updated
Jun 6 closing price
Capitalization
162.64M
60 days until earnings call
Interact to see
Advertisement

LPTX vs SLS

Header iconLPTX vs SLS Comparison
Open Charts LPTX vs SLSBanner chart's image
Leap Therapeutics
Price$0.39
Change-$0.01 (-2.50%)
Volume$490.08K
Capitalization16.38M
SELLAS Life Sciences Group
Price$1.61
Change-$0.02 (-1.23%)
Volume$2.43M
Capitalization162.64M
LPTX vs SLS Comparison Chart
Loading...
LPTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SLS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
LPTX vs. SLS commentary
Jun 08, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is LPTX is a StrongBuy and SLS is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 08, 2025
Stock price -- (LPTX: $0.39 vs. SLS: $1.78)
Brand notoriety: LPTX and SLS are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: LPTX: 10% vs. SLS: 120%
Market capitalization -- LPTX: $16.38M vs. SLS: $162.64M
LPTX [@Biotechnology] is valued at $16.38M. SLS’s [@Biotechnology] market capitalization is $162.64M. The market cap for tickers in the [@Biotechnology] industry ranges from $323.27B to $0. The average market capitalization across the [@Biotechnology] industry is $2.25B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

LPTX’s FA Score shows that 0 FA rating(s) are green whileSLS’s FA Score has 0 green FA rating(s).

  • LPTX’s FA Score: 0 green, 5 red.
  • SLS’s FA Score: 0 green, 5 red.
According to our system of comparison, SLS is a better buy in the long-term than LPTX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

LPTX’s TA Score shows that 6 TA indicator(s) are bullish while SLS’s TA Score has 4 bullish TA indicator(s).

  • LPTX’s TA Score: 6 bullish, 3 bearish.
  • SLS’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, LPTX is a better buy in the short-term than SLS.

Price Growth

LPTX (@Biotechnology) experienced а +7.91% price change this week, while SLS (@Biotechnology) price change was +4.71% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.11%. For the same industry, the average monthly price growth was +10.01%, and the average quarterly price growth was -2.16%.

Reported Earning Dates

SLS is expected to report earnings on Aug 07, 2025.

Industries' Descriptions

@Biotechnology (+4.11% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
SLS($163M) has a higher market cap than LPTX($16.4M). SLS YTD gains are higher at: 71.154 vs. LPTX (-86.435). SLS has higher annual earnings (EBITDA): -31.51M vs. LPTX (-64.24M). LPTX has more cash in the bank: 62.8M vs. SLS (13.9M). LPTX has less debt than SLS: LPTX (376K) vs SLS (1M). LPTX (0) and SLS (0) have equivalent revenues.
LPTXSLSLPTX / SLS
Capitalization16.4M163M10%
EBITDA-64.24M-31.51M204%
Gain YTD-86.43571.154-121%
P/E RatioN/AN/A-
Revenue00-
Total Cash62.8M13.9M452%
Total Debt376K1M38%
FUNDAMENTALS RATINGS
LPTX vs SLS: Fundamental Ratings
LPTX
SLS
OUTLOOK RATING
1..100
1621
VALUATION
overvalued / fair valued / undervalued
1..100
43
Fair valued
57
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
98100
PRICE GROWTH RATING
1..100
9236
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
n/a50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

LPTX's Valuation (43) in the Biotechnology industry is in the same range as SLS (57). This means that LPTX’s stock grew similarly to SLS’s over the last 12 months.

LPTX's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as SLS (100). This means that LPTX’s stock grew similarly to SLS’s over the last 12 months.

LPTX's SMR Rating (98) in the Biotechnology industry is in the same range as SLS (100). This means that LPTX’s stock grew similarly to SLS’s over the last 12 months.

SLS's Price Growth Rating (36) in the Biotechnology industry is somewhat better than the same rating for LPTX (92). This means that SLS’s stock grew somewhat faster than LPTX’s over the last 12 months.

SLS's P/E Growth Rating (100) in the Biotechnology industry is in the same range as LPTX (100). This means that SLS’s stock grew similarly to LPTX’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
LPTXSLS
RSI
ODDS (%)
N/A
Bearish Trend 12 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 12 days ago
90%
Bearish Trend 12 days ago
90%
Momentum
ODDS (%)
Bearish Trend 12 days ago
90%
Bullish Trend 12 days ago
84%
MACD
ODDS (%)
Bullish Trend 12 days ago
90%
Bullish Trend 12 days ago
90%
TrendWeek
ODDS (%)
Bullish Trend 12 days ago
85%
Bearish Trend 12 days ago
89%
TrendMonth
ODDS (%)
Bearish Trend 12 days ago
89%
Bullish Trend 12 days ago
82%
Advances
ODDS (%)
Bullish Trend 12 days ago
86%
Bullish Trend 13 days ago
85%
Declines
ODDS (%)
Bearish Trend 19 days ago
90%
Bearish Trend 27 days ago
87%
BollingerBands
ODDS (%)
Bullish Trend 12 days ago
85%
Bearish Trend 12 days ago
88%
Aroon
ODDS (%)
Bullish Trend 12 days ago
75%
Bullish Trend 12 days ago
80%
View a ticker or compare two or three
Interact to see
Advertisement
LPTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SLS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AAPL200.420.21
+0.10%
Apple
SPY587.73-3.42
-0.58%
SPDR® S&P 500® ETF
BTC.X107802.330000-1192.312500
-1.09%
Bitcoin cryptocurrency
TSLA356.90-5.99
-1.65%
Tesla
GME31.21-3.80
-10.85%
GameStop Corp

LPTX and

Correlation & Price change

A.I.dvisor indicates that over the last year, LPTX has been loosely correlated with SABS. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if LPTX jumps, then SABS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LPTX
1D Price
Change %
LPTX100%
+2.36%
SABS - LPTX
47%
Loosely correlated
-1.12%
INKT - LPTX
43%
Loosely correlated
-5.49%
EVAX - LPTX
31%
Poorly correlated
+11.44%
PLRX - LPTX
29%
Poorly correlated
+5.47%
ALLR - LPTX
29%
Poorly correlated
-2.33%
More

SLS and

Correlation & Price change

A.I.dvisor indicates that over the last year, SLS has been loosely correlated with AKRO. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if SLS jumps, then AKRO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SLS
1D Price
Change %
SLS100%
-7.77%
AKRO - SLS
44%
Loosely correlated
-1.48%
ARGNF - SLS
36%
Loosely correlated
N/A
SABS - SLS
32%
Poorly correlated
-1.12%
ETNB - SLS
29%
Poorly correlated
+0.76%
LPTX - SLS
28%
Poorly correlated
+2.36%
More